Hemodialysis: Clinical Trials

39 trials for Hemodialysis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

26 completed, 9 unknown, 2 withdrawn, 1 enrolling by invitation. 39 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 439Completed 26, Unknown 9, Withdrawn 2, Enrolling by invitation 1, Terminated 1

Follow Hemodialysis: new trials by email Literature Review of Hemodialysis trials Research Report on Hemodialysis

Trials (filtered) newest first · largest first

All 39 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Effect of Sacubitril and Valsartan on Heart Function in Chronic Hemodialysis Patients With HFpEF
Sacubitril / Valsartan - Heart Failure With Preserved Ejection Fraction (HFPEF), Hemodialysis
Phase 4CompletedUniversity Clinical Hospital Mostar522026-01-302026-05-20
Long-term, High Blood Flow Hemoadsorption Therapy in Patients Undergoing Maintenance Hemodialysis
long-term, high blood flow hemoadsorption therapy - Chronic Kidney Diseases, Hemodialysis
Phase 4Enrolling by invitationDongliang Zhang, MD802024-08-282024-12-18
Low-Dose Spironolactone in Hemodialysis Patients With Resistant Hypertension
Spironolactone - Resistant Hypertension, Kidney Failure, Chronic
Phase 4CompletedUniversitas Sebelas Maret212024-08-202026-10-22
Fexofenadine Versus Gabapentin for Uremic Pruritus in Patients on Regular Hemodialysis
Fexofenadine, Gabapentin - Uremic Pruritus, Chronic Kidney Disease-associated Pruritus
Phase 4CompletedTanta University602024-07-012025-04-27
Comparison of Standard Versus High Dose Urokinase for Dysfunctional Tunneled Dialysis Catheters in Haemodialysis Patients: A Randomized Controlled Trial
Urokinase - Hemodialysis, Thrombolytic Therapy
Phase 4CompletedNational Healthcare Group, Singapore442020-10-012025-01-31
Administration of Zepatier (Grazoprevir Plus Elbasvir) in Chronic Hemodialysis (HD) Patients With Hepatitis C
Elbasvir 50 MG / Grazoprevir 100 MG [Zepatier] - Hepatitis C, Hemodialysis
Phase 4CompletedUniversity of Pennsylvania62019-09-222021-12-15
The Effect Dialysis on the Pharmacokinetics of Fexofenadine
Fexofenadine - Hemodialysis
Phase 4UnknownLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's302017-11-292017-11-27
Effect of Sodium Rinsing Fluid on Blood Pressure and Interdialytic Weight Change in Hemodialysis Patients
Dextrose 5%, normal saline - End-Stage Kidney Disease, Hemodialysis
Phase 4UnknownPenang Hospital, Malaysia4342015-10-012015-10-28
Effect of Short-term Synbiotic Treatment on Plasma P-cresol Levels in Hemodialysis Patients
SYNBIOTIC (Probinul neutro®), PLACEBO - Hemodialysis
Phase 4UnknownFederico II University302014-12-012014-12-09
Advancing Renal TRANSplant eFficacy and Safety Outcomes With an eveRolimus-based regiMen (TRANSFORM)
Induction therapy, Corticosteroids, EVR+rCNI - End Stage Renal Disease (ESRD), Chronic Kidney Disease (CKD)
Phase 4CompletedNovartis Pharmaceuticals20372013-12-032019-01-30
Egg Albumin-Based Protein Supplement Versus Renal-specific Supplement in Hemodialysis Patients
Egg albumin-based protein supplement, Renal-specific oral supplement - Protein-Energy Malnutrition, Kidney Failure, Chronic
Phase 4UnknownCentro Medico Lic Adolfo Lopez Mate602013-11-012013-11-11
L-Arginine and Spironolactone Trial in Dialysis-Dependent ESRD
Spironolactone, L-arginine, Placebo - End Stage Renal Disease, Hemodialysis
Phase 4WithdrawnBrigham and Women's Hospital2013-09-012017-05-04
Comparison FX CorDiax 60 in Relation to the FX 60-Dialyzer
dialyzer comparison, Dialyzer - Hemodialysis
Phase 4CompletedHospital Clinic of Barcelona302012-01-012014-04-09
Ischemia In Hemodialysed Patients: Ivabradine Versus Carvedilol
Ivabradine, Carvedilol - Coronary Heart Disease, Angina
Phase 4UnknownUniversity of Campania Luigi Vanvitelli2202011-01-012012-06-28
Comparison of Slow Efficiency Daily Dialysis (SLEDD) With Unfractionated Heparin Versus Citrasate in Critically Ill Patients.
Unfractionated heparin, Citrasate - Acute Kidney Injury, Hemodialysis
Phase 4UnknownUniversity Hospital, Antwerp2502011-01-012010-10-26
Evaluation of the Effectiveness of Paricalcitol Versus Cinacalcet With Low-Dose Vitamin D
Paricalcitol, Cinacalcet - Chronic Kidney Disease, Secondary Hyperparathyroidism
Phase 4CompletedAbbott2722009-11-012012-06-20
The Effect of Different Dosages of Solute Clearance on Outcome in Twice Weekly Hemodialysis Patients
modification of hemodialysis parameters on dialysis machine - Renal Replacement Therapy, Hemodialysis
Phase 4CompletedShanghai Jiao Tong University School of Medicine4002009-06-012016-10-13
Effectiveness and Safety of IV Zemplar in Patients on Hemodialysis and With Secondary Hyperparathyroidism Using iPTH/100 as Initial Dose
Zemplar (paricalcitol) - Secondary Hyperparathyroidism, Renal Insufficiency, Chronic
Phase 4CompletedAbbott1002009-05-012011-10-31
Marinobufagenin as a Target for DIGIBIND in Hypertensive Patients With End-stage Renal Disease
Digoxin immune fab, Placebo - Hypertension, Hemodialysis
Phase 4UnknownNational Institute on Aging (NIA)302009-04-012012-05-25
Effects of Tinzaparin on Cardio-vascular Outcomes and on Blood Lipids in Diabetic Patients on Chronic Hemodialysis
Tinzaparin administration, Heparin administration - Diabetes Mellitus, Hemodialysis
Phase 4WithdrawnAnemia Working Group Romania2009-03-012017-12-22

Showing 20 of 39. Sign in to see all of them.

Narrower conditions

Kidney Failure, Chronic (16)  ·  Renal Insufficiency, Chronic (7)  ·  Cardiovascular Diseases (3)  ·  Anemia, Iron-Deficiency (2)  ·  Diabetes Mellitus (2)  ·  Hyperparathyroidism, Secondary (2)  ·  Hypertension (2)  ·  Uremia (2)  ·  Acute Kidney Injury (1)  ·  Angina Pectoris (1)  ·  Atherosclerosis (1)  ·  Coronary Disease (1)  ·  Critical Illness (1)  ·  Cross Infection (1)  ·  Heart Failure (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (24)  ·  Disease Attributes (23)  ·  Pathologic Processes (23)  ·  Chronic Disease (21)  ·  Female Urogenital Diseases (21)  ·  Female Urogenital Diseases and Pregnancy Complications (21)  ·  Kidney Diseases (21)  ·  Male Urogenital Diseases (21)  ·  Urogenital Diseases (21)  ·  Urologic Diseases (21)  ·  Renal Insufficiency (20)  ·  Renal Insufficiency, Chronic (13)  ·  Nutritional and Metabolic Diseases (9)  ·  Metabolic Diseases (7)  ·  Cardiovascular Diseases (5)

Interventions

Spironolactone (3)  ·  Pharmaceutical Preparations (2)  ·  Ribavirin (2)  ·  fexofenadine (2)  ·  paricalcitol (2)  ·  1 alpha-hydroxyergocalciferol (1)  ·  Adrenal Cortex Hormones (1)  ·  Arginine (1)  ·  Basiliximab (1)  ·  Calcium Carbonate (1)  ·  Carvedilol (1)  ·  Cinacalcet (1)  ·  Cyclosporine (1)  ·  Daptomycin (1)  ·  Enoxaparin (1)

Sponsors

Abbott (2)  ·  Ege University (2)  ·  Hospital Clinic of Barcelona (2)  ·  American Regent, Inc. (1)  ·  Anemia Working Group Romania (1)  ·  Brigham and Women's Hospital (1)  ·  Centro Medico Lic Adolfo Lopez Mate (1)  ·  Chugai Pharma Taiwan (1)  ·  Coordinación de Investigación en Salud, Mexico (1)  ·  Dongliang Zhang, MD (1)  ·  EZUS-LYON 1 (1)  ·  Eulji General Hospital (1)  ·  Federico II University (1)  ·  Kumamoto University (1)  ·  London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (1)

Countries

United States (7)  ·  Italy (4)  ·  Spain (4)  ·  Belgium (3)  ·  Brazil (3)  ·  Japan (3)  ·  Mexico (3)  ·  Turkey (Türkiye) (3)  ·  Chile (2)  ·  China (2)  ·  Czechia (2)  ·  Denmark (2)  ·  Egypt (2)  ·  Germany (2)  ·  Greece (2)

Top investigators

Adel R. Rizkala, Pharm.D., MS (1)  ·  Ahmed M Hussein, PhD (1)  ·  Alfonso M. M Cueto-Manzano, MD, MSc, PhD (1)  ·  Altair J Mocelin, MD PHD (1)  ·  Bruce A Mueller, PharmD (1)  ·  Carol Duffy, D.O.,FACC (1)  ·  Chen-Hua Liu, MD (1)  ·  Chiu-Ching Huang, Professor (1)  ·  Constantin Verzan, MD, PhD (1)  ·  Cristina Capusa, MD, PhD (1)  ·  Deepak Malhotra, MD, PhD (1)  ·  Ercan Ok, M.D (1)  ·  Ercan Ok, MD (1)  ·  Erling B Pedersen, Professor (1)  ·  Gabriel Mircescu, Professor (1)

Results publications

PMID 33586138, PMID 11406727, PMID 17267740, PMID 17396118, PMID 17656473, PMID 18216316, PMID 19034302, PMID 19339089, PMID 20875382, PMID 20881943, PMID 20890189, PMID 21848863, PMID 22172590, PMID 22387567, PMID 24214232, PMID 24500308, PMID 24662288, PMID 25079862, PMID 25823425, PMID 26154643, PMID 27007989, PMID 28182117, PMID 29752413, PMID 31152476, PMID 32633157, PMID 33314078, PMID 34216395, PMID 34620664, PMID 38189593, PMID 40576086, PMID 9590195

NIH funding

2009 (1)